Autism Identification in U.S. Children Reaches 1 in 31, CDC Reports
New data shows improved recognition, especially among Black, Hispanic, and Asian/Pacific Islander children, while geographic gaps in access persist.
The identification of autism among U.S. children has risen to 1 in 31 (3.2%) as of 2022, according to the CDC's latest monitoring report published in April 2025. This marks an increase from the previous estimate of 1 in 36 children, continuing a decades-long trend of improved recognition that researchers attribute to multiple factors including better screening and evolving diagnostic practices.
Key findings from the report:
children has risen to 1 in 31 (3.2%) as of 2022, according to the CDC's latest monitoring report published in April 2025.
- Autism identification rates among 8-year-olds varied significantly by location, ranging from 9.7 to 53.1 per 1,000 children across the 11 monitoring sites (CDC data), suggesting uneven access to diagnostic services.
- Historical racial gaps narrowed substantially, with increased identification among Black (2.9%), Hispanic (2.7%), and Asian/Pacific Islander (3.4%) children — groups previously underrepresented in diagnoses (Johns Hopkins analysis).
- Boys were 3.4 times more likely to be identified than girls, though diagnoses in girls increased more sharply than in previous years (AAP News), potentially reflecting reduced gender bias in diagnostic tools.
Why identification rates are rising: Public health experts emphasize that much of the increase reflects improved awareness, expanded diagnostic criteria in recent editions of the DSM manual, and reduced disparities in access to evaluations. The National Institute of Mental Health notes these factors account for most of the observed increase, while also acknowledging ongoing research into other contributors.
Evolving understanding of autism: The rise in diagnoses, particularly among girls and those with less stereotypical traits, suggests autism is being recognized more broadly. Some researchers caution that diagnostic criteria have expanded significantly since the 1990s (WBUR analysis), while others note this reflects overdue recognition of autism's diverse presentations.
Debunking persistent myths: Despite overwhelming scientific consensus, some groups continue to promote debunked theories linking autism to vaccines or painkillers (FactCheck.org, BBC). Major health organizations stress these claims lack evidence and distract from meaningful support for autistic individuals.
What remains under study: While diagnostic shifts explain much of the increase, researchers continue investigating potential biological and environmental factors that may contribute to autism development, emphasizing these are areas of active investigation rather than settled science (NIMH).
Sources
Common questions
Behind the brief
Adversarial editorial review
Open thread